The Prostate Cancer Dilemma: Selecting Patients... File

To address this dilemma, medical professionals are increasingly using a "triathlon" of advanced tools to better select patients for the right level of care:

The dilemma in prostate cancer management lies in the fine line between lifesaving intervention and unnecessary overtreatment. While early detection can reduce mortality, standard screening methods—like the Prostate-Specific Antigen (PSA) test—often flag slow-growing, "indolent" tumors that would never have caused symptoms or harm in a patient's lifetime. This leads to , which often results in overtreatment through invasive procedures that carry significant side effects like urinary incontinence and erectile dysfunction. The Shift Toward Precision Selection The Prostate Cancer Dilemma: Selecting Patients...